Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR19042 in primary IgA nephropathy
NCT05016323Phase 2Completed
- Sponsor
- Hengrui
- Start
- Sep 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HR19042 in IgA nephropathy (IgAN), sponsored by Hengrui. Started Sep 2021; status: completed.
02
Drugs
HR19042
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT05016323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05016323.